The Supporting Emerging Adults With Diabetes (SEAD) Program: An Adult-Based Real-World Clinical Model That Improves Hospitalizations, Diabetes Technology Uptake, and Glycemic Outcomes in Underserved Young Adults With Type 1 Diabetes
Authors' conclusion
SEAD meaningfully improves clinical outcomes in underserved YA with T1D, especially for publicly insured and high baseline HbA1c levels. Early intervention for at-risk YA with T1D as they enter adult care could reduce inequity in short and long-term outcomes.
Study context
- Population
- Underserved young adults with T1D; mean age 25 years, 27% non-Hispanic Black, 46% Hispanic, 49% public insurance, mean HbA1c 9.2%
- Participants
- 497 adults
- Exposure
- SEAD program vs usual endocrine care
- SEADn = 332
- Usual caren = 165reference
- Outcome
- Incidence of hospitalizations, diabetes technology uptake, and annual change in HbA1c
- Follow-up
- Over 4 years
Methodological detailspropensity-weighted analysis, real-world clinical model
- Propensity-weighted analysis
- Real-world clinical model
Main finding
As reported in the abstract
Hospitalizations; AID uptake; annual HbA1c change
SEAD
−0.37
CI −0.59–-0.15 · % per year
Usual care
−0.26
CI −0.58–0.05 · % per year
SEAD vs Usual careHazard ratio (CI)
Hospitalizations, baseline HbA1c >9%; reduced by 64%
0.36(0.13–0.98)
Hospitalizations, publicly insured; reduced by 74%
0.26(0.07–0.90)
AID uptake; 1.5-times higher
1.51(0.83–2.77)
Observational data: associations, not effects.
Original publication
The Supporting Emerging Adults With Diabetes (SEAD) Program: An Adult-Based Real-World Clinical Model That Improves Hospitalizations, Diabetes Technology Uptake, and Glycemic Outcomes in Underserved Young Adults With Type 1 Diabetes. Diabetes Care. Published 17 September 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →